Discover how base editing technology is helping to address the shortcomings of other gene editing technologies for immunotherapy in this literature review.
In this literature review, you will learn about…
The Pin-point platform technology is available for clinical study and commercialization under a commercial license from Revvity. Pin-point reagents are available for research use only.
The future of immunotherapy gets brighter with base editing